| DNA repair systems as targets of cadmium toxicity C Giaginis, E Gatzidou, S Theocharis Toxicology and applied pharmacology 213 (3), 282-290, 2006 | 298 | 2006 |
| Clinical value of nutritional status in cancer: what is its impact and how it affects disease progression and prognosis? M Mantzorou, A Koutelidakis, S Theocharis, C Giaginis Nutrition and cancer 69 (8), 1151-1176, 2017 | 212 | 2017 |
| Current clinical status on the preventive effects of cranberry consumption against urinary tract infections I Vasileiou, A Katsargyris, S Theocharis, C Giaginis Nutrition Research 33 (8), 595-607, 2013 | 180 | 2013 |
| Alternative measures of lipophilicity: From octanol-water partitioning to IAM retention C Giaginis, A Tsantili-Kakoulidou Journal of Pharmaceutical Sciences 97 (8), 2984-3004, 2008 | 164 | 2008 |
| The association of emotional eating with overweight/obesity, depression, anxiety/stress, and dietary patterns: a review of the current clinical evidence A Dakanalis, M Mentzelou, SK Papadopoulou, D Papandreou, ... Nutrients 15 (5), 1173, 2023 | 159 | 2023 |
| Evaluating Mediterranean diet adherence in university student populations: Does this dietary pattern affect students' academic performance and mental health? M Antonopoulou, M Mantzorou, A Serdari, K Bonotis, G Vasios, ... The International journal of health planning and management 35 (1), 5-21, 2020 | 157 | 2020 |
| Effects of curcumin consumption on human chronic diseases: A narrative review of the most recent clinical data M Mantzorou, E Pavlidou, G Vasios, E Tsagalioti, C Giaginis Phytotherapy Research 32 (6), 957-975, 2018 | 155 | 2018 |
| Current state of the art in HPLC methodology for lipophilicity assessment of basic drugs. A review. C Giaginis, A Tsantili-Kakoulidou Journal of Liquid Chromatography & Related Technologies 31 (1), 79-96, 2007 | 154 | 2007 |
| Lipophilicity and biomimetic properties to support drug discovery F Tsopelas, C Giaginis, A Tsantili-Kakoulidou Expert opinion on drug discovery 12 (9), 885-896, 2017 | 130 | 2017 |
| MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. C Giaginis, S Vgenopoulou, P Vielh, S Theocharis Histology and histopathology 25 (3), 351-370, 2010 | 125 | 2010 |
| Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity C Giaginis, M Georgiadou, K Dimakopoulou, G Tsourouflis, E Gatzidou, ... Digestive diseases and sciences 54, 282-291, 2009 | 120 | 2009 |
| Heat Shock Protein-27,-60 and-90 expression in gastric cancer: association with clinicopathological variables and patient survival C Giaginis, SS Daskalopoulou, S Vgenopoulou, I Sfiniadakis, G Kouraklis, ... BMC gastroenterology 9, 1-10, 2009 | 110 | 2009 |
| NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links I Pateras, C Giaginis, C Tsigris, E Patsouris, S Theocharis Expert Opinion on Therapeutic Targets 18 (9), 1089-1101, 2014 | 102 | 2014 |
| Current evidence on the anticancer potential of Chios mastic gum C Giaginis, S Theocharis Nutrition and cancer 63 (8), 1174-1184, 2011 | 97 | 2011 |
| Nutritional status is associated with the degree of cognitive impairment and depressive symptoms in a Greek elderly population M Mantzorou, K Vadikolias, E Pavlidou, A Serdari, G Vasios, C Tryfonos, ... Nutritional Neuroscience 23 (3), 201-209, 2020 | 93 | 2020 |
| MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker C Giaginis, A Giagini, G Tsourouflis, E Gatzidou, E Agapitos, G Kouraklis, ... Digestive diseases and sciences 56, 777-785, 2011 | 90 | 2011 |
| Epithelial–mesenchymal transition in non small-cell lung cancer N Tsoukalas, E Aravantinou-Fatorou, M Tolia, C Giaginis, ... Anticancer Research 37 (4), 1773-1778, 2017 | 89 | 2017 |
| Peroxisome proliferator-activated receptor-γ (PPAR-γ) ligands as potential therapeutic agents to treat arthritis C Giaginis, A Giagini, S Theocharis Pharmacological Research 60 (3), 60-69, 2009 | 89 | 2009 |
| Clinical significance of HuR expression in human malignancy I Kotta-Loizou, C Giaginis, S Theocharis Medical oncology 31, 1-19, 2014 | 87 | 2014 |
| Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and … C Giaginis, N Tsoukalas, E Bournakis, P Alexandrou, N Kavantzas, ... BMC clinical pathology 14, 1-12, 2014 | 84 | 2014 |
Anna Tsantili-KakoulidouNational andKaapodistrian University of Athenspharm.uoa.gr의 이메일 확인됨
